Home » Medical » Edwards Focuses on the Mitral Valve in RESTORE TrialMedicalEdwards Focuses on the Mitral Valve in RESTORE Trial Manny Johnson January 4, 2021 1 Views Edwards inherited the device used in the trial when it acquired Harpoon Medical for $100 million, plus the potential to have $150 million in pre-specified milestone payments over the next decade.